Financials data is unavailable for this security.
View more
Year on year Jiangsu Jibeier Pharmaceutical Co Ltd grew revenues 31.49% from 654.73m to 860.93m while net income improved 41.65% from 154.67m to 219.09m.
| Gross margin | 87.91% |
|---|---|
| Net profit margin | 27.92% |
| Operating margin | 32.08% |
| Return on assets | 10.81% |
|---|---|
| Return on equity | 12.49% |
| Return on investment | 11.94% |
More ▼
Cash flow in CNYView more
In 2023, cash reserves at Jiangsu Jibeier Pharmaceutical Co Ltd fell by 205.77m. However, the company earned 159.50m from its operations for a Cash Flow Margin of 18.53%. In addition the company used 364.04m on investing activities and also paid 1.23m in financing cash flows.
| Cash flow per share | -- |
|---|---|
| Price/Cash flow per share | -- |
| Book value per share | 11.04 |
|---|---|
| Tangible book value per share | 10.65 |
More ▼
Balance sheet in CNYView more
| Current ratio | 6.19 |
|---|---|
| Quick ratio | 6.04 |
| Total debt/total equity | 0.0061 |
|---|---|
| Total debt/total capital | 0.0061 |
More ▼
Growth rates in CNY
Year on year, growth in dividends per share fell -100.00% while earnings per share excluding extraordinary items rose 41.41%. Additionally, five year annualized earnings per share growth is in-line with the industry average relative to its peers.
| Div yield(5 year avg) | 1.24% |
|---|---|
| Div growth rate (5 year) | -- |
| Payout ratio (TTM) | 0.00% |
| EPS growth(5 years) | 11.17 |
|---|---|
| EPS (TTM) vs TTM 1 year ago | 16.86 |
More ▼
